SCHEMBL8002399

SCHEMBL8002399

Cc1nc(C)n(-c2ccc(-c3nc(-c4ccccn4)n(C)c3Sc3ccc(Cl)cc3)cc2)n1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.62
GRM5 P41594 3/20 0.41
MAPK10 P53779 8/20 0.39
PPP1CA P62136 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DCTPP1 Q9H773 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX12 P18054 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
BRD4 O60885 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
CREBBP Q92793 1/20 0.34
FLT3 P36888 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8006296 0.92 FAAH (0.52) FAAHGRM5MAPK10PPP1CALMNA
SCHEMBL7993064 0.89 FAAH (0.76) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL8003074 0.88 FAAH (0.61) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL8005332 0.86 FAAH (0.61) FAAHGRM5MAPK10PPP1CALMNA
SCHEMBL8008516 0.86 FAAH (0.71) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL8001996 0.85 FAAH (0.64) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL7994178 0.85 FAAH (0.66) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL1303133 0.84 FAAH (0.69) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL1303678 0.84 FAAH (0.69) FAAHGRM5PPP1CALMNAPOLB
SCHEMBL1303197 0.84 FAAH (0.69) FAAHGRM5PPP1CALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885MAPK10 3487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.